GODREJPROP - Rectangle -BO -Daily

353
Godrej Properties Ltd (GODREJPROP) has recently released its Q4 FY25 results, revealing a mixed performance.​

📊 Financial Highlights (Q4 FY25)
Net Profit: Declined by 19% year-on-year to ₹382 crore, compared to ₹471 crore in Q4 FY24. ​

Revenue: Increased by 49% year-on-year to ₹2,122 crore. ​
EBITDA: Slightly decreased by 2% to ₹634 crore. ​
Expenses: Overall expenses rose by 54%, primarily due to increased material consumption costs.
Bookings: Achieved record-high quarterly bookings of ₹10,163 crore, marking a 7% year-on-year increase. ​


FY26 Guidance: The company anticipates new bookings of ₹32,500 crore for FY26, slightly lower than FY25 projections. ​
Market Cap: Approximately ₹65,011 crore. ​
P/E Ratio (TTM): 43.66.
P/B Ratio: 3.86. ​
Debt-to-Equity Ratio: 1.25. ​

The chart **Godrej Properties Ltd (GODREJPROP)** shows a **bullish breakout** from a **rectangle base consolidation pattern**, suggesting a potential uptrend continuation. Here's the technical breakdown:

---

### 🧠 **Chart Pattern Analysis**

- **Pattern:** Rectangle base (accumulation zone) between ~₹1,900 and ~₹2,212
- **Breakout Level:** ₹2,212.50 (horizontal resistance)
- **Breakout Candle:** Strong bullish candle with volume spike (confirmation)
- **Target Projection:**
- Rectangle height: ₹2,212.50 - ₹1,900 ≈ ₹312.50
- Target: ₹2,212.50 + ₹312.50 = **₹2,525** (matches chart projection)

---

### 📌 **Key Levels**

- **Immediate Resistance:** ₹2,249.30 (current price), next at ₹2,525.55
- **Immediate Support:** ₹2,212.50 (breakout level), then ₹1,901.50
- **52-Week High:** ₹3,387.10 (far resistance)

---

### 📊 **Volume Confirmation**

- Noticeable volume spike on the breakout candle.
- Volume > 20-period moving average volume — supports breakout strength.

---

### 🧭 **Outlook**

- **Bullish bias** in the short to medium term.
- A sustained close above ₹2,212.50 with increasing volume favors the target move toward ₹2,525+.
- If price re-tests the breakout zone and holds (₹2,212 area), it would be a healthy sign of support.

---

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.